austria

  1. Chandelier

    Circulating MicroRNA ratios as diagnostic biomarkers for long COVID with an independent validation cohort, 2026, Han et al.

    Circulating MicroRNA ratios as diagnostic biomarkers for long COVID with an independent validation cohort Abstract Background Long COVID is a multisystemic condition with heterogeneous clinical presentations lacking diagnostic biomarkers with discriminatory capacity. This study screened...
  2. Hutan

    Austria: Matthias Wielscher - Medical University of Vienna, Center of Public Health

    Copied from the WE&ME Foundation thread https://www.weandmecfs.org/weme-award-unraveling-biological-differences-in-me-cfs/ 1.3 million euros awarded for ME/CFS research, with 450,000 euros for a project building on the results of DecodeME. This is a quote from the Austrian Science Minister...
  3. Wyva

    Access barriers and the role of central coordination: Long COVID-19 healthcare in Austria, 2025, Gamillscheg et al

    P Gamillscheg, A Laszewska, K Hoffmann, J Simon, S Mayer Abstract Background Long COVID-19 patients experience a multitude of complex symptoms for an extended time, therefore often requiring increased medical care. Despite the global incidence of around 400 million (2023), little is known about...
  4. Yann04

    Open [Survey] Care4PAIS: Healthcare for patients with post-acute infection syndromes (PAIS) and diseases, including ME/CFS

    [I was told this survey is quite long, like over an hour, but can be paused at any time. It’s also open to people outside of austria] https://s2survey.net/pais/index.php?l=eng&q=base&htR=AwA%3D The Following are quotes: What do we want to achieve with this study? This study, sponsored by the...
  5. Wyva

    Barriers and facilitators of healthcare access for LC patients in a universal healthcare system: qualitative evidence from Austria, 2024, Gamillscheg

    Full title: Barriers and facilitators of healthcare access for long COVID-19 patients in a universal healthcare system: qualitative evidence from Austria Peter Gamillscheg, Agata Łaszewska, Stefanie Kirchner, Kathryn Hoffmann, Judit Simon & Susanne Mayer Abstract Background Long COVID-19...
  6. Dolphin

    Review Interdisciplinary, collaborative D-A-CH consensus statement concerning the diagnostic and treatment of ME/CFS, 2024, Hoffmann et al [German]

    https://link.springer.com/article/10.1007/s00508-024-02372-y Interdisziplinäres, kollaboratives D-A-CH Konsensus-Statement zur Diagnostik und Behandlung von Myalgischer Enzephalomyelitis/Chronischem Fatigue-Syndrom Interdisciplinary, collaborative D-A-CH (Germany, Austria and Switzerland)...
  7. Dolphin

    Immunological Patient Stratification in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome 2024 Rohrhofer et al

    Published - see here Preprint https://www.preprints.org/manuscript/202311.2007/v1 Immunological Patient Stratification in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Johanna Rohrhofer , Lisa Hauser , Lisa Lettenmaier , Lena Lutz , Larissa Koidl , Salvatore Alessio Gentile ...
  8. InitialConditions

    Austria: WE&ME Foundation

    "Our foundation supports nationally and internationally recognized research projects, non-profit organizations to support those affected and charity projects to combat diseases such as myalgic encephalomyelitis / chronic fatigue syndrome (ME/CFS) and related diseases. "We can build on a network...
  9. Andy

    Myalgic encephalomyelitis/chronic fatigue syndrome: an overview of current evidence 2023 Ludwig et al

    Abstract Over the past 5 years both media and scientific interest has surged regarding the disorder myalgic encephalomyelitis and chronic fatigue syndrome (ME/CFS), not least because of the clinically similar manifestation in long COVID or post-COVID. In this review we discuss the process of...
  10. M

    A multi-omics based anti-inflammatory immune signature characterizes long COVID-19 syndrome, 2022, Kovarik et al

    This thread starts with discussion of the preprint. Now that the research has been published, the thread title has been changed and the abstract posted in post #13 Preprint Multi-omics provide evidence for an anti-inflammatory immune signature and metabolic alterations in patients with Long...
  11. LarsSG

    Post-acute COVID-19 is characterized by gut viral antigen persistence in inflammatory bowel diseases, 2022, Zollner et al

    Abstract Background and aims: The coronavirus disease 2019 (COVID-19) pandemic affects populations, societies and lives for more than two years. Long-term sequelae of COVID-19, collectively termed the post-acute COVID-19 syndrome, are rapidly emerging across the globe. Here, we investigated...
  12. Andy

    Austria: Petition: ME / CFS: Recognition, Medical Care and Protection of the Affected, and Research Funding, closes 22 Nov 2021

    I'm relying on Google translation here, if any errors are spotted please let me know. Quote: Myalgic Encephalomyelitis / Chronic Fatigue Syndrome - ICD-10 G93.3 ME / CFS is a severe multi-system disease that currently affects between 26,000 and 80,000 people in Austria [1]. Depending on its...
  13. MSEsperanza

    Evaluation of Immune Dysregulation in an Austrian Patient Cohort Suffering from Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, 2021, Lutz et al

    Lutz L, Rohrhofer J, Zehetmayer S, Stingl M, Untersmayr E. Evaluation of Immune Dysregulation in an Austrian Patient Cohort Suffering from Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Biomolecules. 2021; 11(9):1359. https://doi.org/10.3390/biom11091359 free full text...
  14. MSEsperanza

    News from Austria and Switzerland

    A thread for general news, events, articles etc from Austria and Switzerland.
  15. ME/CFS Science Blog

    ME/CFS segment on Austrian TV

    There was a segment on ME/CFS on an Austrian TV news program. A direct link to the fragment can be found here: https://tvthek.orf.at/profile/Magazin-1/13890330/Magazin-1/14032702/Chronisches-Erschoepfungssyndrom/14595793
Back
Top Bottom